Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,028,000 | 10,727,000 | 9,309,000 | 9,530,000 | 9,072,000 |
| Depreciation Amortization | 5,471,000 | N/A | 4,462,000 | N/A | 5,980,000 |
| Income taxes - deferred | N/A | N/A | 1,498,000 | -2,166,000 | -2,435,000 |
| Accounts receivable | -513,000 | N/A | N/A | N/A | -732,000 |
| Accounts payable and accrued liabilities | 378,000 | N/A | N/A | N/A | 195,000 |
| Other Working Capital | -863,000 | -2,804,000 | -2,832,000 | -165,000 | 1,370,000 |
| Other Operating Activity | 396,000 | 5,974,000 | 737,000 | 6,995,000 | 859,000 |
| Operating Cash Flow | $11,897,000 | $13,897,000 | $13,174,000 | $14,194,000 | $14,309,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -333,000 | 1,917,000 | -29,000 | -1,123,000 | 1,595,000 |
| PPE Investments | -2,211,000 | -2,564,000 | -2,855,000 | -2,376,000 | -2,106,000 |
| Net Acquisitions | -16,507,000 | 558,000 | -175,000 | -1,993,000 | -569,000 |
| Purchase Of Investment | -264,000 | 1,131,000 | -204,000 | -166,000 | -151,000 |
| Sale Of Investment | 166,000 | 431,000 | 313,000 | 220,000 | 59,000 |
| Purchase Sale Intangibles | -517,000 | -534,000 | -379,000 | -197,000 | 423,000 |
| Other Investing Activity | 8,365,000 | -592,000 | -402,000 | -237,000 | 380,000 |
| Investing Cash Flow | $-10,784,000 | $881,000 | $-3,352,000 | $-5,675,000 | $-792,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 451,000 | -107,000 | 596,000 | -1,737,000 | -3,054,000 |
| Debt Issued | 4,596,000 | 6,024,000 | 93,000 | 1,979,000 | 281,000 |
| Debt Repayment | -3,086,000 | -2,599,000 | -2,022,000 | -704,000 | -28,000 |
| Common Stock Issued | 1,581,000 | N/A | 1,693,000 | 414,000 | 163,000 |
| Common Stock Repurchased | -6,071,000 | -6,915,000 | -2,926,000 | -511,000 | -6,815,000 |
| Dividend Paid | -6,643,000 | -6,950,000 | -6,203,000 | -6,116,000 | -5,571,000 |
| Other Financing Activity | -4,000 | 2,400,000 | 0 | 0 | 0 |
| Financing Cash Flow | $-9,176,000 | $-8,147,000 | $-8,769,000 | $-6,675,000 | $-15,024,000 |
| Exchange Rate Effect | -286,000 | -295,000 | 82,000 | -1,000 | -103,000 |
| Beginning Cash Position | 13,023,000 | 6,687,000 | 5,552,000 | 3,709,000 | 5,319,000 |
| End Cash Position | 4,674,000 | 13,023,000 | 6,687,000 | 5,552,000 | 3,709,000 |
| Net Cash Flow | $-8,349,000 | $6,336,000 | $1,135,000 | $1,843,000 | $-1,610,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,897,000 | 13,897,000 | 13,174,000 | 14,194,000 | 14,309,000 |
| Capital Expenditure | -2,449,000 | -2,624,000 | -2,903,000 | -2,458,000 | -2,167,000 |
| Free Cash Flow | 9,448,000 | 11,273,000 | 10,271,000 | 11,736,000 | 12,142,000 |